VAERS reports by lot

Moderna COVID-19 lot 013B22A: VAERS reports

163 VAERS reports list lot 013B22A as a Moderna COVID-19 vaccine, received between 2022-07-15 and 2023-09-01. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
163
Reports
9%
Marked serious
2
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5719%
Injection-site / Local reaction4414%
Cardiac / Cardiovascular3712%
Musculoskeletal3311%
Respiratory3211%
Gastrointestinal3110%
Neurological289%
Dermatological (non-injection-site)196%
Allergic / Anaphylactic176%
Thrombotic / Hematological31%
Psychiatric / Neuropsychiatric31%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas14
Virginia13
Colorado9
California8
North Carolina6
Georgia6
Pennsylvania6
South Carolina5
New Jersey5
Washington5
New York5
Iowa4

Reports by month received

2022-078
2022-0842
2022-0919
2022-1040
2022-1110
2022-1227
2023-013
2023-025
2023-034
2023-053
2023-071
2023-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.